IRIS - Res&Arch Institutional Research Information System - Research & Archive

DI GIORGIO, CRISTINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.690
AS - Asia 1.198
EU - Europa 816
SA - Sud America 158
Continente sconosciuto - Info sul continente non disponibili 90
AF - Africa 37
OC - Oceania 4
Totale 3.993
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.565
SG - Singapore 526
IT - Italia 296
CN - Cina 179
HK - Hong Kong 132
RU - Federazione Russa 120
BR - Brasile 114
IE - Irlanda 102
VN - Vietnam 98
BD - Bangladesh 78
DE - Germania 72
CA - Canada 62
KR - Corea 51
FR - Francia 47
GB - Regno Unito 30
FI - Finlandia 28
IN - India 21
NL - Olanda 20
TR - Turchia 20
IQ - Iraq 17
PL - Polonia 17
AT - Austria 16
MX - Messico 16
UA - Ucraina 14
JP - Giappone 12
SE - Svezia 12
AR - Argentina 11
PK - Pakistan 11
SV - El Salvador 11
CO - Colombia 10
BE - Belgio 9
EC - Ecuador 9
ES - Italia 9
ZA - Sudafrica 9
CR - Costa Rica 8
SA - Arabia Saudita 8
ID - Indonesia 7
GT - Guatemala 6
IL - Israele 6
VE - Venezuela 6
JM - Giamaica 5
MA - Marocco 5
AE - Emirati Arabi Uniti 4
CI - Costa d'Avorio 4
TN - Tunisia 4
TT - Trinidad e Tobago 4
BO - Bolivia 3
CH - Svizzera 3
EE - Estonia 3
KW - Kuwait 3
KZ - Kazakistan 3
MY - Malesia 3
PH - Filippine 3
SC - Seychelles 3
AU - Australia 2
BS - Bahamas 2
CZ - Repubblica Ceca 2
DK - Danimarca 2
DZ - Algeria 2
ET - Etiopia 2
GR - Grecia 2
KE - Kenya 2
LB - Libano 2
NI - Nicaragua 2
NZ - Nuova Zelanda 2
OM - Oman 2
PR - Porto Rico 2
RO - Romania 2
SN - Senegal 2
SY - Repubblica araba siriana 2
UY - Uruguay 2
AI - Anguilla 1
AM - Armenia 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BG - Bulgaria 1
BW - Botswana 1
BY - Bielorussia 1
BZ - Belize 1
CL - Cile 1
CW - ???statistics.table.value.countryCode.CW??? 1
CY - Cipro 1
DO - Repubblica Dominicana 1
GA - Gabon 1
GP - Guadalupe 1
HN - Honduras 1
HU - Ungheria 1
IM - Isola di Man 1
IR - Iran 1
LC - Santa Lucia 1
LK - Sri Lanka 1
LT - Lituania 1
MK - Macedonia 1
MN - Mongolia 1
MU - Mauritius 1
NO - Norvegia 1
NP - Nepal 1
PE - Perù 1
PY - Paraguay 1
Totale 3.898
Salva come PNG Salva come JPEG
Città #
Singapore 417
San Jose 197
Ashburn 183
Chandler 133
Hong Kong 132
Perugia 102
Dublin 97
Santa Clara 70
Council Bluffs 68
Seoul 51
Moscow 45
Los Angeles 44
New York 44
Boardman 41
Munich 39
Beijing 37
Lauterbourg 34
Piscataway 23
Hanoi 22
Ho Chi Minh City 22
Milan 22
San Mateo 22
Dong Ket 21
Ann Arbor 20
Phoenix 19
Princeton 19
Toronto 18
North Bergen 17
Rome 17
Medford 16
São Paulo 16
Warsaw 16
Altamura 15
Brooklyn 14
Dallas 14
Lawrence 13
Montreal 13
Helsinki 12
The Dalles 12
Tokyo 12
Turku 12
Wilmington 11
Amsterdam 10
Hefei 10
Naples 10
Nuremberg 10
San Salvador 10
Brussels 9
Buffalo 9
Chicago 9
New Orleans 9
Seattle 9
Atlanta 8
Baghdad 8
Charlotte 8
Denver 8
Orem 8
Stockholm 8
Des Moines 7
Frankfurt am Main 7
San José 7
Vicenza 7
Vienna 7
Calgary 6
Florence 6
Houston 6
Mexico City 6
Poplar 6
Redwood City 6
San Francisco 6
Chennai 5
Guatemala City 5
London 5
Miami 5
Quito 5
Riverbank 5
Abidjan 4
Andover 4
Ankara 4
Bologna 4
Columbus 4
Den Haag 4
Dubai 4
Gualdo Cattaneo 4
Istanbul 4
Johannesburg 4
Lahore 4
Lappeenranta 4
Querétaro 4
Riyadh 4
Saint Petersburg 4
Secaucus 4
Turin 4
Can Tho 3
Curitiba 3
Fortaleza 3
Haiphong 3
Jeddah 3
Karachi 3
Katy 3
Totale 2.491
Salva come PNG Salva come JPEG
Nome #
Increasing the Astrophysical Reach of the Advanced Virgo Detector via the Application of Squeezed Vacuum States of Light 151
Development of dual GPBAR1 agonist and RORγt inverse agonist for the treatment of inflammatory bowel diseases 129
The aryl hydrocarbon receptor (AhR) mediates the counter-regulatory effects of pelargonidins in models of inflammation and metabolic dysfunctions 125
Identification of Cysteinyl-leukotriene-receptor 1 antagonists as ligands for the bile acid receptor GPBAR1 123
Defective Bile Acid Signaling Promotes Vascular Dysfunction, Supporting a Role for G-Protein Bile Acid Receptor 1/Farnesoid X Receptor Agonism and Statins in the Treatment of Nonalcoholic Fatty Liver Disease 118
Discovery of a AHR pelargonidin agonist that counter-regulates Ace2 expression and attenuates ACE2-SARS-CoV-2 interaction 118
Atorvastatin protects against liver and vascular damage in a model of diet induced steatohepatitis by resetting FXR and GPBAR1 signaling 117
The Bile Acid Receptor GPBAR1 Modulates CCL2/CCR2 Signaling at the Liver Sinusoidal/Macrophage Interface and Reverses Acetaminophen-Induced Liver Toxicity 111
Analysis of Oral and Gut Microbiota Composition in Children with Dental Caries by NGS Approaches 110
Discovery of a Novel Multi-Strains Probiotic Formulation with Improved Efficacy toward Intestinal Inflammation 110
Opposite effects of the FXR agonist obeticholic acid on Mafg and Nrf2 mediate the development of acute liver injury in rodent models of cholestasis 109
The bile acid activated receptors GPBAR1 and FXR exert antagonistic effects on autophagy 107
Liver GPBAR1 Associates With Immune Dysfunction in Primary Sclerosing Cholangitis and Its Activation Attenuates Cholestasis in Abcb4−/− Mice 105
Combinatorial targeting of GPBAR1 and CYSLTR1 reveals a mechanistic role for bile acids and leukotrienes in drug induced liver injury 105
Bile Acids Activated Receptors in Inflammatory Bowel Disease 105
Allo-lithocholic acid, a microbiome derived secondary bile acid, attenuates liver fibrosis 103
Discovery of a Potent and Orally Active Dual GPBAR1/CysLT1R Modulator for the Treatment of Metabolic Fatty Liver Disease 103
GLP-1 Mediates Regulation of Colonic ACE2 Expression by the Bile Acid Receptor GPBAR1 in Inflammation 102
GPBAR1 Functions as Gatekeeper for Liver NKT Cells and provides Counterregulatory Signals in Mouse Models of Immune-Mediated Hepatitis 98
Combinatorial therapy with BAR502 and UDCA resets FXR and GPBAR1 signaling and reverses liver histopathology in a model of NASH 97
GPBAR1 Activation by C6-Substituted Hyodeoxycholane Analogues Protect against Colitis 97
Beneficial effects of UDCA and norUDCA in a rodent model of steatosis are linked to modulation of GPBAR1/FXR signaling 95
The leukemia inhibitory factor regulates fibroblast growth factor receptor 4 transcription in gastric cancer 92
Discovery of BAR502, as potent steroidal antagonist of leukemia inhibitory factor receptor for the treatment of pancreatic adenocarcinoma 90
Activation of GPBAR1 attenuates vascular inflammation and atherosclerosis in a mouse model of NAFLD-related cardiovascular disease 90
Obeticholic Acid: An Update of Its Pharmacological Activities in Liver Disorders 88
Repositioning Mifepristone as a Leukaemia Inhibitory Factor Receptor Antagonist for the Treatment of Pancreatic Adenocarcinoma 84
Design, Synthesis, and Pharmacological Evaluation of Dual FXR-LIFR Modulators for the Treatment of Liver Fibrosis 83
Bile acids serve as endogenous antagonists of the Leukemia inhibitory factor (LIF) receptor in oncogenesis 82
Discovery of a Novel Class of Dual GPBAR1 Agonists-RORγt Inverse Agonists for the Treatment of IL-17-Mediated Disorders 80
Next-Generation Sequencing Analysis of Gastric Cancer Identifies the Leukemia Inhibitory Factor Receptor as a Driving Factor in Gastric Cancer Progression and as a Predictor of Poor Prognosis 78
Microbial-derived bile acid reverses inflammation in IBD via GPBAR1 agonism and RORγt inverse agonism 76
Modeling Inflammatory Bowel Disease by Intestinal Organoids 76
Immunology of bile acids regulated receptors 73
BAR502/fibrate conjugates: synthesis, biological evaluation and metabolic profile 67
Bile Acids-Based Therapies for Primary Sclerosing Cholangitis: Current Landscape and Future Developments 67
Organoids as ex vivo culture system to investigate infection-host interaction in gastric pre-carcinogenesis 67
Leukemia inhibitory factor promotes human cholangiopathies, and its inhibition improves cholestasis in Abcb4 −/− mice 63
Harnessing the Estradienone Scaffold to Develop Dual GPBAR1 and LIFR Modulators for Liver Fibrosis 61
Current Landscape and Evolving Therapies for Primary Biliary Cholangitis 56
LIFR antagonism reverses epithelial pro-CAF programs in pancreatic ductal adenocarcinoma 40
A bile acid–GPBAR1 network supports anti-inflammatory and anti-fibrotic benefits of probiotics in colitis 40
Tumor-Derived LIF Promotes GDF15-Driven Cachexia and Adverse Outcomes in Gastric Cancer 37
Bile acids as mediators of microbiota signaling in entero-hepatic disorders 30
Pharmacological inhibition of LIF signaling reverses PD-L1-mediated immune suppression in gastric cancer 21
The Farnesoid X receptor-bile acid axis contributes to immune evasion in gastric cancer and its inhibition enhances efficacy of anti-PD-L1 therapy 14
Totale 3.993
Salva come PNG Salva come JPEG
Categoria #
all - tutte 18.291
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.291
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022100 0 0 0 0 1 1 11 21 3 15 16 32
2022/2023409 27 61 3 35 38 46 0 22 151 2 14 10
2023/2024204 10 15 4 6 12 1 47 28 19 9 33 20
2024/2025771 9 57 39 52 46 74 50 79 158 35 113 59
2025/20261.773 108 110 90 240 248 138 252 86 168 161 77 95
2026/2027608 58 88 98 311 53 0 0 0 0 0 0 0
Totale 3.993